Search clinical trials for: NY-ESO-1b peptide plus CpG 7909 and Montanide® ISA-51
Total 11 results
-
Ludwig Institute for Cancer ResearchCompletedCancer | NeoplasmGermany
-
Nina BhardwajCancer Research Institute, New York CityCompleted
-
Centre Hospitalier Universitaire VaudoisLudwig Institute for Cancer ResearchCompleted
-
University of Southern CaliforniaNational Cancer Institute (NCI)CompletedRecurrent Melanoma | Stage IV Melanoma | Mucosal Melanoma | Ciliary Body and Choroid Melanoma, Medium/Large Size | Ciliary Body and Choroid Melanoma, Small Size | Iris Melanoma | Metastatic Intraocular Melanoma | Recurrent Intraocular Melanoma | Stage IV Intraocular Melanoma | Stage IIIA Melanoma | Stage... and other conditionsUnited States
-
Oryx GmbH & Co. KGCompleted
-
H. Lee Moffitt Cancer Center and Research InstituteBristol-Myers Squibb; National Cancer Institute (NCI); MedarexCompleted
-
Nina BhardwajCancer Research Institute, New York City; Ludwig Institute for Cancer Research and other collaboratorsCompleted
-
National Institute of Allergy and Infectious Diseases...PepTcell Limited (t/a SEEK)CompletedMosquito-Borne Infectious DiseasesUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteBristol-Myers Squibb; National Cancer Institute (NCI); MedarexCompletedMelanoma (Skin)United States
-
Roswell Park Cancer InstituteEisai Inc.CompletedRecurrent Ovarian Epithelial Cancer | Recurrent Primary Peritoneal Cavity Cancer | Recurrent Fallopian Tube CancerUnited States
-
Children's Oncology GroupNational Cancer Institute (NCI); University College, London; Medical Research...CompletedMetastatic Osteosarcoma | Localized OsteosarcomaUnited States, Canada, Australia, New Zealand, Puerto Rico, Switzerland